RegentAtlantic Capital’s CDK Global, Inc. CDK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-3,964
Closed -$217K 480
2019
Q4
$217K Sell
3,964
-186
-4% -$9.56K 0.01% 437
2019
Q3
$200K Buy
+4,150
New +$199K 0.01% 433
2019
Q2
Sell
-3,922
Closed -$231K 451
2019
Q1
$231K Buy
+3,922
New +$214K 0.02% 398
2018
Q4
Sell
-3,950
Closed -$247K 442
2018
Q3
$247K Sell
3,950
-22
-0.6% -$1.4K 0.02% 394
2018
Q2
$258K Hold
3,972
0.02% 366
2018
Q1
$252K Buy
3,972
+166
+4% +$11.6K 0.02% 369
2017
Q4
$271K Hold
3,806
0.02% 371
2017
Q3
$240K Hold
3,806
0.02% 378
2017
Q2
$236K Buy
3,806
+133
+4% +$8.34K 0.02% 374
2017
Q1
$239K Hold
3,673
0.02% 366
2016
Q4
$219K Sell
3,673
-63
-2% -$3.6K 0.02% 368
2016
Q3
$214K Buy
+3,736
New +$215K 0.02% 363
2015
Q1
Sell
-3,753
Closed -$153K 1028
2014
Q4
$153K Buy
+3,753
New +$133K 0.01% 392

Other funds holding CDK

RegentAtlantic Capital's CDK Position: Q1 2020 in Review

RegentAtlantic Capital sold out of CDK Global, Inc. (CDK) in Q1 2020, closing a stake of 3,964 shares — an estimated $217K sold.

RegentAtlantic Capital first reported a position in CDK in Q4 2014 and held it in 13 quarters. The position peaked at $271K in Q4 2017. 467 funds tracked by Wall St. Rank hold CDK as of Q1 2020.

  • RegentAtlantic Capital reported no remaining CDK Global, Inc. position as of Q1 2020 after selling out during the quarter.
  • RegentAtlantic Capital sold 3,964 CDK Global, Inc. shares in Q1 2020, an estimated $217K.
  • RegentAtlantic Capital first reported a position in CDK Global, Inc. in Q4 2014 and held it in 13 quarters.
  • RegentAtlantic Capital's CDK Global, Inc. position peaked at $271K in Q4 2017.
  • 467 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q1 2020.

Based on RegentAtlantic Capital's 13F filing for Q1 2020, filed 14 May 2020.